Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director

GENELINK INC (GNLK) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/22/2014 8-K Quarterly results
12/17/2013 10-K/A Annual Report for the period ended December 31, 2012 [amend]
11/27/2013 10-K/A Annual Report for the period ended December 31, 2012 [amend]
11/14/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2013 10-Q Quarterly Report for the period ended September 30, 2013
08/14/2013 10-Q Quarterly Report for the period ended June 30, 2013
07/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/11/2013 8-K Submission of Matters to a Vote of Security Holders, Other Events
05/15/2013 10-Q Quarterly Report for the period ended March 31, 2013
05/02/2013 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
03/29/2013 10-K Annual Report for the period ended December 31, 2012
02/11/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2012 10-Q Quarterly Report for the period ended September 30, 2012
10/09/2012 D/A Form D - Notice of Exempt Offering of Securities [amend]
10/09/2012 SC 13D MARSHALL JON A reports a 13% stake in GeneLink, Inc.
10/04/2012 3 MARSHALL JON A (10% Owner) has filed a Form 3 on GENELINK INC
09/07/2012 4 RICCIARDI ROBERT P (Director) has filed a Form 4 on GENELINK INC
Txns: Granted 100,000 options to buy @ $0.03, valued at $3k
09/07/2012 4 KASTEN BERNARD L (CEO) has filed a Form 4 on GENELINK INC
Txns: Granted 100,000 options to buy @ $0.03, valued at $3k
09/07/2012 4 Boyle Douglas M (Director) has filed a Form 4 on GENELINK INC
Txns: Granted 500,000 options to buy @ $0.03, valued at $15k
09/07/2012 4 Monton James A. (Director) has filed a Form 4 on GENELINK INC
Txns: Granted 100,000 options to buy @ $0.03, valued at $3k
08/24/2012 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/14/2012 10-Q Quarterly Report for the period ended June 30, 2012
07/16/2012 8-K Form 8-K - Current report
05/21/2012 10-Q Quarterly Report for the period ended March 31, 2012
05/15/2012 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
05/14/2012 10-K Annual Report for the period ended December 31, 2011
05/11/2012 8-K/A Form 8-K - Current report [amend]
05/10/2012 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State...
Docs: "GeneLink Reports 2011 Financial Results 2010 Re-audited and Restated"
05/04/2012 8-K/A Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Cross, Fernandez & Riley LLP filed pursuant to Item 304 of Regulation S-K"
04/27/2012 8-K Form 8-K - Current report
03/30/2012 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/20/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Cross, Fernandez and Riley, LLC",
"Research report of Cross, Fernandez and Riley, LLC"
03/09/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Buckno Lisicky & Company, P.C. filed pursuant to Item 304(a)(3) of Regulation S-K"
02/16/2012 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "GENELINK BIOSCIENCES COMPLETES SALE OF GENEWIZE LIFE SCIENCES"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy